APA (7th ed.) Citation

SETHI, B., SAHAY, R. K., TIWASKAR, M. H., DHEDIYA, R., GAURAV, K., RATHOD, R. T., . . . SHAH, S. (2023). 889-P: Effectiveness of Dapagliflozin as Add-on to Metformin Alone or Metformin with Other Oral Antidiabetic Drug Classes in Type 2 Diabetes Mellitus—A Multicentre, Retrospective, Real-World Evidence Study. Diabetes (New York, N.Y.), 72(Supplement_1), 1. https://doi.org/10.2337/db23-889-P

Chicago Style (17th ed.) Citation

SETHI, BIPIN, RAKESH K. SAHAY, MANGESH H. TIWASKAR, RAJNISH DHEDIYA, KUMAR GAURAV, RAHUL T. RATHOD, BHAVESH P. KOTAK, GAURI D. DHANAKI, and SNEHAL SHAH. "889-P: Effectiveness of Dapagliflozin as Add-on to Metformin Alone or Metformin with Other Oral Antidiabetic Drug Classes in Type 2 Diabetes Mellitus—A Multicentre, Retrospective, Real-World Evidence Study." Diabetes (New York, N.Y.) 72, no. Supplement_1 (2023): 1. https://doi.org/10.2337/db23-889-P.

MLA (9th ed.) Citation

SETHI, BIPIN, et al. "889-P: Effectiveness of Dapagliflozin as Add-on to Metformin Alone or Metformin with Other Oral Antidiabetic Drug Classes in Type 2 Diabetes Mellitus—A Multicentre, Retrospective, Real-World Evidence Study." Diabetes (New York, N.Y.), vol. 72, no. Supplement_1, 2023, p. 1, https://doi.org/10.2337/db23-889-P.